Medicare Enrolled
Dr. Yousef Tadros, MD
Pathology - Anatomic · Buffalo Grove, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tadros from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tadros?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tadros
Dr. Yousef Tadros is a pathology - anatomic specialist in Buffalo Grove, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Tadros performed 114,260 Medicare services across 14,998 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tadros received a total of $57 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tadros is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 0% volume in IL
$57 industry payments
Medicare Practice Summary
Medicare Utilization ↗114,260
Medicare services
Top 0% in IL for pathology - anatomic
14,998
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,348 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
35,939 | $34 | $55 |
| Lab specimen collection travel allowance Reimbursement for one-way travel miles to collect laboratory specimens from patients who are homebound or in a nursing home. |
29,547 | $1 | $1 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
12,819 | $34 | $38 |
| Multiplex respiratory virus test (COVID-19, flu, RSV) A laboratory test that uses a multiplex amplified probe technique to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus types A and B, and respiratory syncytial virus (RSV). |
11,133 | $140 | $200 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
8,171 | $69 | $85 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
2,732 | $34 | $60 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
2,719 | $34 | $60 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
2,718 | $34 | $55 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
2,717 | $34 | $55 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
2,520 | $34 | $55 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
487 | $8 | $8 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
464 | $10 | $11 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
235 | $34 | $60 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
175 | $16 | $17 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
165 | $13 | $14 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
148 | $8 | $11 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
138 | $10 | $10 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
129 | $3 | $30 |
| Digestive tract pathogen nucleic acid test, 12-25 targets A laboratory test that uses nucleic acid amplification to detect multiple types or subtypes of pathogens in the digestive tract. The test analyzes between 12 and 25 specific targets simultaneously. |
120 | $407 | $1,140 |
| Trichomonas vaginalis nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the Trichomonas vaginalis parasite. This method identifies the presence of the organism responsible for trichomoniasis. |
118 | $34 | $60 |
| Chlamydia trachomatis nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Chlamydia trachomatis bacteria in a sample. |
117 | $34 | $60 |
| Gonorrhea nucleic acid amplification test A laboratory test that uses amplified probe techniques to detect the genetic material of gonorrhea bacteria. This method identifies the presence of the infection by analyzing nucleic acids from the sample. |
117 | $34 | $60 |
| Digestive tract pathogen nucleic acid test, 6-11 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of pathogens in the digestive tract. The test analyzes 6 to 11 specific targets simultaneously. |
113 | $258 | $1,000 |
| Gardnerella vaginalis detection test A laboratory test that uses an amplified probe technique to detect the presence of Gardnerella vaginalis bacteria. |
110 | $34 | $60 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
95 | $8 | $9 |
| Valproic acid level test A blood test that measures the total amount of valproic acid in your system. This helps healthcare providers monitor medication levels to ensure they are within a safe and effective range. |
70 | $13 | $14 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
64 | $4 | $30 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
56 | $7 | $7 |
| Prealbumin (protein) level | 42 | $14 | $15 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
40 | $9 | $9 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
39 | $29 | $31 |
| Respiratory virus test for SARS-CoV-2, influenza A/B, and RSV A laboratory test that detects the presence of SARS-CoV-2 (COVID-19), influenza A, influenza B, and respiratory syncytial virus (RSV) in an upper respiratory specimen. |
32 | $140 | $400 |
| Iron level test | 27 | $6 | $7 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
26 | $38 | $41 |
| Immunoassay test for other organisms A laboratory test using immunoassay techniques to detect the presence of specific organisms. |
26 | $12 | $40 |
| Clostridium difficile toxin test A stool test that uses an immunoassay technique to detect toxins produced by the Clostridium difficile bacteria. |
25 | $12 | $40 |
| Phenytoin level test A blood test to measure the total amount of phenytoin in your system. This helps healthcare providers monitor medication levels and adjust dosing. |
24 | $13 | $14 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
16 | $8 | $8 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
14 | $5 | $5 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
13 | $15 | $16 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$57
Total received (2023-2024)
Avg $28/year across 2 years
Bottom 35% in IL for pathology - anatomic
2
Companies
2
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$57 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$37
2023
$20
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$37
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2023-2024) ›
Boston Scientific Corporation
$37
Blue Earth Diagnostics Limited
$20
Top 3 companies account for 100.0% of all-time payments
Associated products mentioned in payments ›
Axumin · Rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pathology - anatomics within 10 mi
313
Per 100K population
44.0
County median income
$108,917
Nearest hospital
NORTHWESTERN LAKE FOREST HOSPITAL
7.0 mi
7.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tadros is a mixed practice specialist, with above-average Medicare volume (top 0% in IL), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tadros experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Tadros performed 35,939 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tadros receive payments from pharmaceutical companies?
Yes. Dr. Tadros received a total of $57 from 2 companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tadros's costs compare to other pathology - anatomics in Buffalo Grove?
Dr. Tadros's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tadros) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pathology - Anatomics in Buffalo Grove
Browse pathology - anatomics in Buffalo Grove ranked by procedure volume and transparency data.
Highest volume
Top Pathology - Anatomics in IL
Pathology - anatomics ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pathology - Anatomics in IL
Which IL pathology - anatomics receive the most from drug and device companies.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology